Business

Briefs: Akorn moves ahead with cancer drug

Posted December 05, 2007 10:00 pm

BUFFALO GROVE -- Akorn Inc. submitted a new drug application on behalf of Serum Institute of India Ltd. Akorn and Serum signed an exclusive drug development and distribution agreement for 16 anti-cancer injectable products in 2004. Since then, Serum has constructed a manufacturing facility for producing liquid and lyophilized oncolytic drug products. The new application is for ANDA, a drug product that is given for many different types of cancer and has an estimated U.S. market size of about $53 million. Akorn expects to launch the drug in 2010.

Technology picked for new refinery

DES PLAINES -- UOP LLC, a Honeywell company, announced Wednesday that Newfoundland & Labrador Refining Corp. has selected UOP to supply technology, basic engineering services and equipment for a new fuel refinery to be built in the Placentia Bay area of Newfoundland and Labrador, Canada. Basic engineering design is currently under way, and start-up of the complex is planned for 2011.

Article Comments

Article Categories
Buffalo Grove Business Communities Cook County Counties Des Plaines

Article Comments

Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.